Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 170,720 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) major shareholder Bradley A. Keywell sold 170,720 shares of Tempus AI stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the completion of the transaction, the insider now directly owns 15,993,729 shares in the company, valued at $566,977,693.05. The trade was a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company's stock are required to disclose their sales and purchases with the SEC.

Tempus AI Price Performance

Shares of TEM traded up $0.40 during mid-day trading on Friday, hitting $35.15. The company's stock had a trading volume of 2,434,717 shares, compared to its average volume of 3,919,255. The stock's 50-day moving average is $46.80 and its two-hundred day moving average is $47.09. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Needham & Company LLC reiterated a "buy" rating and issued a $56.00 price target on shares of Tempus AI in a report on Tuesday. Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research note on Tuesday. Wolfe Research began coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an "outperform" rating and a $60.00 price target on the stock. Bank of America increased their price target on Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus cut shares of Tempus AI from a "buy" rating to a "hold" rating and raised their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $56.36.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $30,000. FNY Investment Advisers LLC acquired a new stake in shares of Tempus AI during the 4th quarter valued at about $67,000. Sandia Investment Management LP bought a new position in shares of Tempus AI during the second quarter valued at $136,000. Vestor Capital LLC bought a new stake in Tempus AI during the 3rd quarter worth approximately $153,000. Finally, Stifel Financial Corp acquired a new position in shares of Tempus AI during the third quarter worth approximately $218,000. Institutional investors own 24.22% of the company's stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.